Pathological mechanisms of human T-cell lymphotropic virus type I-associated myelopathy (HAM/TSP)

References

• Abe M, Umehara F, Kubota R, Moritoyo T, Izumo S, Osame M (1999). Activation of macrophage/microglias with ex-pression of MRP8 and MRP14 is associated with the le-sional activities in the spinal cord lesions in HTLV-I as-sociated myelopathy. J Neurol 246: 358–364.
   Google Scholar
• Anderson P, Nagler-Anderson C, O'Brien C, Levine H, Watkins S, Slayter HS, Blue ML, Schlossman SF (1990). A monoclonal antibody reactive with a 15-kD a cytoplas-mic granule-associated protein defines a subpopulation of CD8+ T lymphocytes. Jimmunol 144: 574–582.
   PubMedGoogle Scholar
• Bangham C (2000). The immune response to HTLV-I. Curr Opin Immunol 12: 397–402.
   Google Scholar
• Furukawa Y, Yamashita M, Usuku K, Izumo S, Nakagawa M, Osame M (2000). Phylogenetic subgroups of HTLV-I in tax gene and their association with different risk to HTLV-I-associated myelopathy/tropical spastic para-praresis. I Infect Dis 182: 1343–1349.
   Google Scholar
• Gessain A, Barin F, Vernant JC, Gout O, Maurs L, Calender A, de The G (1985). Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 2: 407–410.
   PubMed Web of Science ®Google Scholar
• Giraudon P, Burt S, Bernard A, Thomas N, Beeline MF (1996). Extracellular matrix-remodeling metallopro-teinases and infection of the central nervous system with retrovirus human T-lymphotropic virus type I (HTLV-I). Prog Neurobiol 49: 169–184.
   Google Scholar
• Hanon E, Stinchcombe JC, Saito M, Asquith BE, Taylor GP, Tanaka Y, Weber JN, Griffiths GM, Bangham CR (2000). Fratricide among CD8(±) T lymphocytes naturally in-fected with human T cell lymphotropic virus type I. Immunity 13: 657–664.
   PubMed Web of Science ®Google Scholar
• Inoue A, Koh CS, Sakai T, Yamazaki M, Yanagisawa N, Usuku K, Osame M (1997). Detection of the soluble form of the Fas molecule in patients with multiple sclero-sis and human T-lymphotropic virus type I-associated myelopathy. J Neuroimmunol 75: 141–146.
   Google Scholar
• Izumo S, Ijichi T, Higuchi I, Tashiro A, Takahashi K, Osame M (1992). Neuropathology of HTLV-I-associated myelopathy: A report of two autopsy cases. Acta Paedi-atr Jpn 34: 358–364.
   Google Scholar
• Jacobson S, Shida H, McFarlin DE, Fauci AS, Koenig S (1990). Circulating CD8+ cytotoxic lymphocytes spe-cific for HTLV-I in patients with HTLV-I associated neu-rological disease. Nature 348: 245–248.
   PubMed Web of Science ®Google Scholar
• Jeffery KJM, Usuku K, Hall SE, Matsumoto W, Taylor GP, Procter J, Bunce M, Ogg GS, Welsh KI, Weber JN, Lloyd AL, Nowak MA, Nagai M, Kodama D, Izumo S, Osame M, Bangham CR (1999). HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy. Proc Nat] Acad Sci USA 96: 3848–3853.
   PubMed Web of Science ®Google Scholar
• Kaplan J, Osame M, Kubota H (1990). The risk of de-veloping HTLV-I associated myelopathy/tropical spas-tic paraparesis (HAM/TSP) among persons infected with HTLV-I. J AIDS 3: 1096–1101.
   PubMed Web of Science ®Google Scholar
• Kawahigashi N, Furukawa Y, Saito M, Usuku K, Osame M (1998). Predominant expression of Fas ligand mRNA in CD8+ T lymphocytes inpatients with HTLV-I-associated myelopathy. J Neuroimmunol 90: 199–206.
   Google Scholar
• Kubota R, Osame M, Jacobson S (2000). Retrovirus: Human T-cell lymphotropic virus type I-associated dis-eases and immune dysfunction. In: Effects of Microbes on the Immune System. Cunningham MW, Fujinami RS (eds). Lippincott Williams & Wilkins: Philadelphia, pp 349–371.
   Google Scholar
• Kubota R, Umehara F, Izumo S, Ijichi S, Matsumuro K, Yashiki S, Fujiyoshi T, Sonoda S, Osame M (1994). HTLV-I proviral DNA amount correlates with infiltrat-ing CD4+ lymphocytes in the spinal cord from patients with HTLV-I-associated myelopathy. I Neuroimmunol 53: 23–29.
   Google Scholar
• Lehky TJ, Fox CH, Koenig S, Levin MC, Flerlage N, Izumo S, Sato E, Raine CS, Osame M, Jacobson S (1995). Detection of human T-lymphotropic virus type I (HTLV-I) tax mRNA in the central nervous system of HTLV-I-associated myelopathy/tropical spastic para-paresis patients by in situ hybridization. Ann Neurol 37: 167–175.
   PubMed Web of Science ®Google Scholar
• Levin MC, Lee SM, Kalume F, Morcos Y, Dohan FC, Jr, Hasty KA, Callaway JC, Zunt J, Desiderio DM, Stuart JM (2002). Autoimmunity due to molecular mimicry as a cause of neurological disease. Nat Med 8: 509–513.
   PubMed Web of Science ®Google Scholar
• Matsuoka E, Takenouchi H, Hashimoto K, Kashio N, Moritoyo T, Higuchi I, Isashiki Y, Sato E, Osame M, Izumo S (1998). Perivascular T-cells are infected with HTLV-I in the spinal cord lesions with HAM/TSP: Dou-ble staining of immunohistochemistry and PCR in situ hybridization. Acta Neuropathol 96: 340–346.
   PubMed Web of Science ®Google Scholar
• Moe Moe Aye, Matsuoka E, Moritoyo Umehara F, Suehara M, Hokezu Y, Yamanaka H, Isashiki Y, Osame M, Izumo S (2000). Histopathological analysis of four autopsy cases of HTLV-I-associated myelopathy/tropical spas-tic paraparesis: Inflammatory changes occur simulta-neously in the entire central nervous system. Acta Neuropathol 100: 245–252.
   Google Scholar
• Moritoyo T, Reinhart TA, Moritoyo H, Sato E, Izumo S, Osame M, Haase AT (1996). Human T-lymphotropic virus type I-associated myelopathy and tax gene expres-sion in CD4+ T lymphocytes. Ann Neurol 40: 84–90.
   PubMedGoogle Scholar
• Nagai M, Brennan MB, Sakai JA, Mora CA, Jacobson S (2001). CD8+ T cells are an in vivo reservoir for human T-cell lymphotropic virus type I. Blood 98: 1858–1861.
   PubMed Web of Science ®Google Scholar
• Nagai M, Jacobson S (2001). Immunopathogenesis of human T cell lymphotropic virus type I-associated myelopathy. Curr Opin Neurol 14: 381–386.
   PubMed Web of Science ®Google Scholar
• Nagai M, Usuku K, Matsumoto W, Kodama D, Takenouchi N, Moritoyo T, Hashiguchi S, Ichinose M, Bangham CR, Izumo S, Osame M (1998). Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: High proviral load strongly predisposes to HAM/TSP. J NeuroVirol 4: 586–593.
   Google Scholar
• Nakagawa M, Izumo S, Ijichi S, Kubota H, Arimura K, Kawabata M, Osame M (1995). HTLV-I-associated myelopathy: Analysis of 213 patients based on clinical features and laboratory findings. J NeuroVirol 1: 50–61.
   Google Scholar
• Osame M (1990). Review of WHO Kagoshima Meeting and Diagnostic Guidelines for HAM/TSP. In: Human Retrovi-rology: HTLV. Blattner WA (ed). Raven Press: New York, pp 191–197.
   Google Scholar
• Osame M, Arima H, Norimatsu K, Kawahira, Okatsu Y, Nagamatsu K, Igata A (1975). Epidemiostatistical stud-ies of muscular atrophy in Southern Kyushu (Kagoshima and Okinawa prefectures). Jpn J Med 14: 230–231.
   Google Scholar
• Osame M, Igata A (1989). The history of discovery and clinico-epidemiology of HTLV-I-associated myelopathy (HAM). Jpn JMed 28: 412–414.
   Google Scholar
• Osame M, Matsumoto M, Usuku K, Izumo S, Ijichi N, Amitani H, Tara M, Igata A (1987). Chronic progres-sive myelopathy associated with elevated antibodies to human T-lymphotropic virus type I and adult T-cell leukemia like cells. Ann Neurol 21: 117–122.
   PubMed Web of Science ®Google Scholar
• Osame M, Usuku K, Izumo S, Ijichi N, Amitani H, Igata A, Matsumoto M, Tara M (1986). HTLV-I associated myelopathy, a new clinical entity. Lancet I: 1031–1032.
   Google Scholar
• Saito M, Nakamura N, Nagai M, Shirakawa K, Sato H, Kawahigashi N, Furukawa Y, Usuku K, Nakagawa M, Izumo S, Osame M (1998). Increased levels of solu-ble Fas ligand in CSF of rapidly progressive HTLV-I-associated myelopathy/tropical spastic paraparesis. I Neuroimmunol 98: 221–226.
   Google Scholar
• Tian Q, Streuli M, Saito H, Schlossman SF, Anderson P (1991). A polyadenylate binding protein localized to the granules of cytolytic lymphocytes induces DNA fragmentation in target cells. Cell 67: 629–639.
   PubMed Web of Science ®Google Scholar
• Umehara F, Abe M, Koeeda Y, Izumo S, Osame M (2000). Axonal damage revealed by accumulation of /3-amyloid precursor protein in HTLV-I-associated myelopathy. I Neurol Sci 176: 95–101.
   Google Scholar
• Umehara F, Itoh K, Michizono K, Abe M, Izumo S, Osame M (2002). Involvement of Fas/Fas ligand system in the spinal cords of HTLV-I-associated myelopathy. Acta Neuropathol 91: 343–350.
   Google Scholar
• Umehara F, Izumo S, Nakagawa M, Ronquillo AT, Takahashi K, Sato E, Osame M (1993). Immunocy-tochemical analysis of the cellular infiltrate in the spinal cord lesions in HTLV-I-associated myelopathy. I Neuropathol Exp Neurol 52: 424–430.
   Google Scholar
• Umehara F, Izumo S, Ronquillo AT, Matsumuro K, Osame M (1994a). Cytokine expression in the spinal cord le-sions in HTLV-I-associated myelopathy. I Neuropathol Exp Neurol 53: 72–77.
   Google Scholar
• Umehara F, Izumo S, Takeya M, Sato E, Osame M (1996). Ex-pression of adhesion molecules and monocyte chemoat-tractant protein-1 (MCP-1) in the spinal cord lesions in HTLV-I-associated myelopathy. Acta Neuropathol 91: 343–350.
   Google Scholar
• Umehara F, Nakamura A, Izumo S, Kubota R, Ijichi S, Kashio N, Hashimoto K, Usuku K, Sato E, Osame M (1994b). Apoptosis of T- lymphocytes in the spinal cord lesions in HTLV-I-associated myelopathy: A possible mechanism to control viral infection in the central ner-vous system. I Neuropathol Exp Neurol 53: 617–624.
   Google Scholar
• Umehara F, Okada Y, Fujimoto N, Abe M, Izumo S, Osame M (1998). Expression of matrix metallopro-teinases and tissue inhibitors of metalloproteinases in HTLV-I-associated myelopathy. I Neuropathol Exp Neurol 57: 839–849.
   Google Scholar
• World Health Organization (1989). Report of the scientific group on HTLV-I and associated diseases, Kagoshima, Japan, December 1988. Available from Manila, Philippines: World Health Organization, March 1989; Virus diseases. Human T-lymphotropic virus type I, HTLV-1. WHO Wkly Epidemiol Rec 49: 382–383. (Abstract.)
   Google Scholar